An investigation on behalf of investors in Applied Therapeutics, Inc. (NASDAQ:APLT) shares over potential wrongdoing at Applied Therapeutics, Inc. was announced.

San Diego, CA -- (SBWire) -- 04/11/2022 --Certain directors of Applied Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties.

Investors who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Applied Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.

New York based Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications.

On January 3, 2022, Applied Therapeutics, Inc disclosed that "[f]ollowing discussions with the FDA at the end of the year, the Company has decided to hold on submitting an NDA for AT-007 for treatment of Galactosemia pending additional discussions with the agency. Although the Galactosemia program had previously been discussed in the context of an NDA for Accelerated Approval based on reduction in galactitol, the FDA has now indicated that clinical outcomes data will likely be required for approval."

Shares of Applied Therapeutics, Inc. (NASDAQ: APLT) declined from $10.13 per share on December 22, 2021, to as low as $1.45 in March 2022.

Those who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.